Cannabinoid drugs

Details for Australian Patent Application No. 2001264680 (hide)

Owner Recht, L. Zurier, R. Indevus Pharmaceuticals, Inc.

Inventors Burstein, Sumner

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001264680

PCT Pub. Number WO01/87297

Priority 60204935 17.05.00 US

Filing date 17 May 2001

Wipo publication date 26 November 2001

Acceptance publication date 14 September 2006

International Classifications

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/19 (2006.01)

A61K 31/20 (2006.01)

Event Publications

4 September 2003 Change of Name(s) of Applicant(s), Section 104

  Zurier, Robert; Atlantic Technology Ventures, Inc.; Recht, Lawrence The name of the applicant has been changed to Recht, Lawrence; Zurier, Robert; Manhattan Pharmaceuticals, Inc.

14 September 2006 Assignment before Grant

  Manhatten Pharmaceuticals, Inc; Recht, Lawrence; Zurier, Robert The application has been assigned to Recht, Lawrence; Zurier, Robert; Indevus Pharmaceuticals, Inc. 2002

14 September 2006 Application Accepted

  Published as AU-B-2001264680

18 January 2007 Standard Patent Sealed

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001264681-Haplotypes of the osm gene

2001264679